BackgroundCheck.run
Search For

Paul V Lemley, 3761 Massachusetts Ave, Westover, NY 13790

Paul Lemley Phones & Addresses

61 Massachusetts Ave, Johnson City, NY 13790   

Gettysburg, PA   

Work

Company: Gettysbrew Address: 248 Hunterstown Rd, Gettysburg, PA 17325 Phones: 717-3371001 Position: Owner Industries: Eating Places

Mentions for Paul V Lemley

Paul Lemley resumes & CV records

Resumes

Paul Lemley Photo 29

Partner

Location:
Gettysburg, PA
Industry:
Recreational Facilities And Services
Work:
Battlefield Brew Works
Partner
Us Army 1980 - 1981
Company Commander
Education:
Massachusetts Institute of Technology 1983 - 1986
Doctorates, Doctor of Philosophy, Philosophy, Chemistry
United States Military Academy at West Point 1970 - 1974
Bachelors, Bachelor of Science, Engineering
Skills:
Military, Army, Security Clearance, Operational Planning, Command, Military Operations, National Security, Program Management, Leadership, Dod, Organizational Leadership, Defense, Strategic Planning, Project Planning, Government, Operations Management, Team Building, Military Experience, Leadership Development, Training
Languages:
Portuguese
Paul Lemley Photo 30

Paul Lemley

Paul Lemley Photo 31

Paul Lemley

Paul Lemley Photo 32

Paul Lemley

Paul Lemley Photo 33

Paul Lemley

Paul Lemley Photo 34

Paul Lemley

Location:
United States

Publications & IP owners

Us Patents

Vaccine Against Ricin Toxin

US Patent:
5453271, Sep 26, 1995
Filed:
Jun 28, 1993
Appl. No.:
8/082422
Inventors:
Paul V. Lemley - Gettysburg PA
Donald A. Creasia - Frederick MD
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:
A61K 3900
A61K 3938
A61K 39395
A61K 3940
A61K 3942
A61K 4944
US Classification:
4241841
Abstract:
It is now possible to immunize susceptible mammals against the pathological effect of exposure to rice, including inhalation of ricin, by administration of an immunogenic effective amount of ricin toxin sub-units, including subunits of both the A chain and the B chain of the ricin toxin given separately to provide safe, efficacious protection.

Monoclonal Antibody Against Ricin A Chain

US Patent:
5626844, May 6, 1997
Filed:
Dec 27, 1994
Appl. No.:
8/363204
Inventors:
Paul V. Lemley - Gettysburg PA
D. Craig Wright - Gaithersburg MD
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:
A61K 39395
C07K 1616
A61M 520
US Classification:
4241411
Abstract:
Monoclonal antibodies against the A chain of ricin have been found to be ective in protecting mammals from morbidity arising from exposure to ricin toxin. The neutralizing action of the antibodies does not appear to be mediated by complement or by immunoprecipitation. The antibodies of the invention are characterized as of isotype IgG1 having the binding characteristics which include: a) binding specifically to the neutralizing epitope of the ricin A chain and b) providing in vitro protection of at least 95% of EL-4 cells from 100. eta. g/mL ricin challenge when said antibody is present in the tissue culture at a level of at least 1000. eta. g/mL.

Method For Treating Tumors With A Toxin

US Patent:
5667786, Sep 16, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/486200
Inventors:
Paul V. Lemley - Gettysburg PA
Arthur E. Frankel - Charleston SC
Assignee:
Novavax, Inc. - Columbia MD
International Classification:
A61K 3902
A61K 3800
US Classification:
4242361
Abstract:
A method for treating a tumor is provided, which comprises the steps of preliminarily immunizing a patient in need of antitumor treatment with a toxin or toxin surrogate vaccine in an amount which is effective to generate an immune response to the toxin in the patient, thereby providing systemic protection from the toxin to the patient, and subsequently administering the toxin to the patient in an amount which is effective to kill tumor cells. The toxin may be any suitable toxin, for example ricin, abrin, gelonin or diphtheria.

Method For Treating Tumors With A Toxin

US Patent:
6060066, May 9, 2000
Filed:
Jul 18, 1997
Appl. No.:
8/897090
Inventors:
Paul V. Lemley - Gettysburg PA
Arthur E. Frankel - Charleston SC
Assignee:
Novavax, Inc. - Columbia MD
International Classification:
A61K 3902
US Classification:
4242361
Abstract:
A method for treating a tumor is provided, which comprises the steps of preliminarily immunizing a patient in need of antitumor treatment with a toxin or toxin surrogate vaccine in an amount which is effective to generate an immune response to the toxin in the patient, thereby providing systemic protection from the toxin to the patient, and subsequently administering the toxin to the patient in an amount which is effective to kill tumor cells. The toxin may be any suitable toxin, for example ricin, abrin, gelonin or diphtheria.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.